An 8-Week Refractory Chronic Cough Study (MK-7264-021)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This was an 8-week randomized, parallel, double-blind, placebo-controlled study of gefapixant (AF-219) in participants with refractory chronic cough.
Epistemonikos ID: 8b94349f0826aa4959e85128499026b23ad50fa8
First added on: May 12, 2024